Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 103Other hematologic neoplasm 54Lymphoid 33Plasma cell 21Classical hematology 18Dermatologic 9Thoracic 4Sarcoma 4Other neoplasm 3Gynecologic 3CNS 3Genitourinary 2Gastrointestinal 2Breast 2Other solid neoplasm 1NET 1Head & Neck 1Endocrine 1

Conditions

Advanced Solid Tumors 173Advanced Solid Tumor 150Solid Tumor 129Mesothelioma 88Mesothelioma, Malignant 81Solid Tumors 79Hematopoietic and Lymphatic System Neoplasm 47Solid Tumor, Adult 35Carcinoma, Non-Small-Cell Lung 32Retinoblastoma 29Ovarian Neoplasms 26Melanoma 24Colorectal Neoplasms 22Pancreatic Neoplasms 21Stomach Neoplasms 20Sarcoma 20Lung Neoplasms 19Carcinoma, Renal Cell 18Uterine Cervical Neoplasms 16Esophageal Neoplasms 16Neoplasms 15Malignant Solid Neoplasm 15Neoplasm Metastasis 14Hematopoietic and Lymphoid System Neoplasm 14Advanced or Metastatic Solid Tumors 14Triple Negative Breast Neoplasms 13Solid Tumor Malignancies 13Small Cell Lung Carcinoma 13Advanced Malignant Solid Tumor 13Urinary Bladder Neoplasms 12

Interventions

ruxolitinib 1avelumab 1Pemetrexed 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Primary Myelofibrosis × Other solid neoplasm × 1 year × Clear all
NCT04328844 2026-03-30

A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

iOnctura

Phase 1 Active not recruiting
210 enrolled
DermatologicLymphoidMyeloidOther solid neoplasmThoracic

Uveal Melanoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Mesothelioma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡